Article info
Editorial commentary
CMT2CC associated with NEFH mutations: a predominantly motor neuronopathy
- Correspondence to Dr Davide Pareyson, Rare Neurodegenerative and Neurometabolic Diseases Unit - Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano 20133 Lombardia, Italy; davide.pareyson{at}istituto-besta.it
Citation
CMT2CC associated with NEFH mutations: a predominantly motor neuronopathy
Publication history
- Received July 27, 2021
- Accepted July 27, 2021
- First published September 13, 2021.
Online issue publication
July 06, 2022
Article Versions
- Previous version (13 September 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.